CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
1-Year Return
31.81%
This Quarter Return
+7.53%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$1.07B
AUM Growth
+$162M
(+18%)
Cap. Flow
+$137M
Cap. Flow
% of AUM
12.79%
Top 10 Holdings %
Top 10 Hldgs %
37.33%
Holding
532
New
105
Increased
323
Reduced
47
Closed
36
Top Buys
| 1 |
Apple
AAPL
|
$9.9M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$7.06M |
| 3 |
NVIDIA
NVDA
|
$6.46M |
| 4 |
Microsoft
MSFT
|
$6.23M |
| 5 |
ProShares Ultra Gold
UGL
|
$5.73M |
Top Sells
| 1 |
Alibaba
BABA
|
$5.72M |
| 2 |
GSK
GSK
|
$5.14M |
| 3 |
Pinduoduo
PDD
|
$3.46M |
| 4 |
Procter & Gamble
PG
|
$2.91M |
| 5 |
Synopsys
SNPS
|
$2.45M |
Sector Composition
| 1 | Technology | 38.06% |
| 2 | Healthcare | 25.43% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Communication Services | 10.24% |
| 5 | Financials | 3.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Novartis
NVS
$251B
| $1.09M | 0.1% |
+11,220
| New | +$1.09M |
|
|
TEM
152
Tempus AI, Inc. Class A Common Stock
TEM
$13.8B
| $1.09M | 0.1% |
+32,315
| New | +$1.09M |
|
153
SPDR Gold Trust
GLD
$112B
| $1.09M | 0.1% |
4,500
+3,000
| +200% | +$726K |
|
154
Nuvalent
NUVL
$5.83B
| $1.09M | 0.1% |
13,913
+2,496
| +22% | +$195K |
|
155
Accenture
ACN
$159B
| $1.09M | 0.1% |
3,094
+843
| +37% | +$297K |
|
|
VRNA
156
Verona Pharma
VRNA
$9.2B
| $1.06M | 0.1% |
22,848
+1,807
| +9% | +$83.9K |
|
|
157
Pinduoduo
PDD
$177B
| $1.05M | 0.1% |
10,870
-35,700
| -77% | -$3.46M |
|
158
iShares Gold Trust
IAU
$52.6B
| $1.04M | 0.1% |
21,000
-10,000
| -32% | -$495K |
|
159
Vertiv
VRT
$47.4B
| $1.02M | 0.1% |
+9,000
| New | +$1.02M |
|
160
CSX Corp
CSX
$60.6B
| $1.01M | 0.09% |
31,383
+6,792
| +28% | +$219K |
|
161
Crinetics Pharmaceuticals
CRNX
$3.35B
| $1.01M | 0.09% |
19,664
+4,271
| +28% | +$218K |
|
162
IBM
IBM
$232B
| $1M | 0.09% |
4,561
+1,260
| +38% | +$277K |
|
163
Alkermes
ALKS
$4.94B
| $987K | 0.09% |
34,308
+2,637
| +8% | +$75.8K |
|
164
Thermo Fisher Scientific
TMO
$186B
| $984K | 0.09% |
1,891
+519
| +38% | +$270K |
|
165
Krystal Biotech
KRYS
$4.35B
| $955K | 0.09% |
6,098
+572
| +10% | +$89.6K |
|
166
TAL Education Group
TAL
$6.17B
| $952K | 0.09% |
+95,000
| New | +$952K |
|
167
Philip Morris
PM
$251B
| $936K | 0.09% |
7,698
+2,112
| +38% | +$257K |
|
168
Airbnb
ABNB
$75.8B
| $926K | 0.09% |
7,045
+1,464
| +26% | +$192K |
|
169
Danaher
DHR
$143B
| $919K | 0.09% |
4,000
-2,395
| -37% | -$550K |
|
170
PACCAR
PCAR
$52B
| $910K | 0.09% |
8,533
+1,884
| +28% | +$201K |
|
171
Roper Technologies
ROP
$55.8B
| $907K | 0.08% |
1,745
+385
| +28% | +$200K |
|
172
Copart
CPRT
$47B
| $900K | 0.08% |
15,681
+3,475
| +28% | +$199K |
|
173
GE Aerospace
GE
$296B
| $897K | 0.08% |
5,368
+1,435
| +36% | +$240K |
|
174
Goldman Sachs
GS
$223B
| $896K | 0.08% |
+1,564
| New | +$896K |
|
175
Arcellx
ACLX
$4.03B
| $879K | 0.08% |
11,466
+1,127
| +11% | +$86.4K |
|